UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.316-326

2018

Volltextzugriff (PDF)

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

Expert opinion on biological therapy, 2009-09, Vol.9 (9), p.1163-1176

2009

Volltextzugriff (PDF)

Do courts grant women their inheritance shares? An analysis of case law in India

World development, 2024-10, Vol.182, p.106688, Article 106688

2024

Volltextzugriff (PDF)

Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review

Veterinary sciences, 2019-05, Vol.6 (2), p.48

2019

Volltextzugriff (PDF)

The 13th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum

Molecular therapy, 2022-04, Vol.30 (4), p.1361-1363

2022

Volltextzugriff (PDF)

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma

Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100736-100736, Article 100736

2023

Volltextzugriff (PDF)

Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters

PloS one, 2013-09, Vol.8 (9), p.e73759-e73759

2013

Volltextzugriff (PDF)

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

mSphere, 2021-06, Vol.6 (3), p.e0017021-e0017021

2021

Volltextzugriff (PDF)

Mutations in the Stalk Region of the Measles Virus Hemagglutinin Inhibit Syncytium Formation but Not Virus Entry

Journal of Virology, 2010-10, Vol.84 (20), p.10913-10917

2010

Volltextzugriff (PDF)

422 Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A452-A452

2021

Volltextzugriff (PDF)

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs

Human gene therapy. Clinical development, 2013-12, Vol.24 (4), p.174-181

2013

Volltextzugriff (PDF)

The 13 th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum

Molecular therapy, 2022-04, Vol.30 (4), p.1361

2022

Volltextzugriff (PDF)

Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy

Molecular therapy. Oncolytics, 2014-01, Vol.1 (C), p.14005-14005, Article 14005

2014

Volltextzugriff (PDF)

Differential Contributions of Motilin Receptor Extracellular Domains for Peptide and Non-peptidyl Agonist Binding and Activity

The Journal of biological chemistry, 2006-05, Vol.281 (18), p.12390-12396

2006

Volltextzugriff (PDF)

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS602-TPS602

2024

Volltextzugriff (PDF)

Prevalence of self-care practices and assessment of their sociodemographic risk factors among diabetes in the urban slums of Bengaluru

Journal of family medicine and primary care, 2017-04, Vol.6 (2), p.218-221

2017

Volltextzugriff (PDF)

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with pembrolizumab, in patients with neuroendocrine carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS657-TPS657

2023

Volltextzugriff (PDF)

Translation of oncolytic viruses in sarcoma

Molecular Therapy: Oncology, 2024-09, Vol.32 (3), p.200822, Article 200822

2024

Volltextzugriff (PDF)

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.509-509

2022

Volltextzugriff (PDF)

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

Cancer gene therapy, 2012-07, Vol.19 (7), p.443-450

2012

Volltextzugriff (PDF)

Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1747-1747

2021

Volltextzugriff (PDF)

Abstract P190: Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P190-P190

2021

Volltextzugriff (PDF)

Curative one-shot systemic virotherapy in murine myeloma

Leukemia, 2012-08, Vol.26 (8), p.1870-1878

2012

Volltextzugriff (PDF)

Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model

Molecular therapy, 2016-12, Vol.24 (12), p.2109-2117

2016

Volltextzugriff (PDF)

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3172-TPS3172

2020

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(66)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(29)
Humans
(15)
Animals
(14)
Medicine, Research & Experimental
(11)
Research & Experimental Medicine
(11)
Biotechnology & Applied Microbiology
(8)
Oncology
(8)
Vesicular Stomatitis Indiana Virus - Genetics
(8)
Mice
(7)
Vesicular Stomatitis Virus
(7)
Multiple Myeloma - Therapy
(6)
Oncolysis
(6)
Oncolytic Virotherapy
(6)
Oncolytic Viruses - Genetics
(6)
Physical Sciences
(6)
Tumors
(6)
Viruses
(6)
Cell Line, Tumor
(5)
Female
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

Do courts grant women their inheritance shares? An analysis of case law in India

Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review

The 13th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma

Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

Mutations in the Stalk Region of the Measles Virus Hemagglutinin Inhibit Syncytium Formation but Not Virus Entry

422 Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs

The 13 th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum

Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy

Differential Contributions of Motilin Receptor Extracellular Domains for Peptide and Non-peptidyl Agonist Binding and Activity

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma

Prevalence of self-care practices and assessment of their sociodemographic risk factors among diabetes in the urban slums of Bengaluru

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with pembrolizumab, in patients with neuroendocrine carcinoma

Translation of oncolytic viruses in sarcoma

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer

Abstract P190: Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma

Curative one-shot systemic virotherapy in murine myeloma

Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy

Suchergebnisse filtern